404: Page not Found

To find an doctor profile, first select a location from the home page and then search.

If you can't find the page you're looking for using the navigation above, please Contact Us.

 
The Selection Process

In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.

Read more…


NIH urges women to protect their heart health and to encourage others to do the same

During American Heart Month in February 2013, The Heart Truth campaign of the National Heart, Lung, and Blood Institute (NHLBI) will celebrate the stories of women taking action to protect their hearts and who are inspiring and motivating others to make heart-healthy lifestyle changes.

Read more.

New Guides Compare Benefits and Risks of GERD Treatments

New plain-language publications from the U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ) compare the benefits and risks of treatments for gastroesophageal reflux disease (GERD), a digestive condition that affects millions of Americans and can be treated with medications or surgery.

Read more.

Genetic Study of Patients with Inflammatory Bowel Disease Could Lead to Better Treatments

Genetic variation in patients with inflammatory bowel disease (IBD) appears to play a major role in determining how sick they will become and could provide a roadmap for more effective treatments.

Read more.

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers planned for umbilical cord blood transplantation following a myeloablative conditioning regimen (treatment such as radiation or chemotherapy). 

Read more.

What is Super Doctors?
Super Doctors Magazine

Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.

Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.

Click here for more details



Browse Super Doctors
Browse Medical Specialties

More ...

Browse
Locations

More ...